| Title: |
Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies |
| Authors: |
Bertolotto, AntonioAff1, IDs40120020001917_cor1; Arroyo, RafaelAff2; Celius, Elisabeth G.Aff3; Comi, GiancarloAff4; Havrdova, Eva KubalaAff5; Honeycutt, William DavidAff6; Hunter, Samuel F.Aff7; Izquierdo, GuillermoAff8; Kornek, BarbaraAff9; Miller, TamaraAff10; Mitsikostas, Dimos D.Aff11; Singer, Barry A.Aff12; Ziemssen, TjalfAff13; Chung, LukeAff14; Daizadeh, NadiaAff14; Afsar, SalmanAff14; Hashemi, LobatAff14; Senior, PeterAff15 |
| Source: |
Neurology and Therapy. 9(2):443-457 |
| Database: |
Springer Nature Journals |